Brickell Biotech, Inc. (BBI)
Company Info
| ISIN | US10802T1051 |
|---|---|
| CUSIP | 10802T105 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $6.75M |
|---|---|
| EPS | -$0.42 |
| Revenue (TTM) | $4.64M |
| Gross Profit (TTM) | -$27.83M |
| EBITDA (TTM) | -$30.50M |
| Year Range | $0.45 - $2.58 |
| Target Price | $17.83 |
| Short % | 6.73% |
| Short Ratio | 0.62 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Brickell Biotech, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Brickell Biotech, Inc. had a return of -40.67% year-to-date (YTD) and -46.39% in the last 12 months. Over the past 10 years, Brickell Biotech, Inc. had an annualized return of -56.39%, while the S&P 500 had an annualized return of 9.70%, indicating that Brickell Biotech, Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -40.67% | 18.49% |
| 1 month | 0.39% | 4.20% |
| 6 months | 53.42% | 6.60% |
| 1 year | -46.39% | 15.43% |
| 5 years (annualized) | -70.70% | 11.59% |
| 10 years (annualized) | -56.39% | 9.70% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 5.92% | 29.82% | 4.09% | -12.33% | 51.56% | -6.95% | -6.38% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Brickell Biotech, Inc. (BBI) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
BBI Brickell Biotech, Inc. | -0.44 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Brickell Biotech, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Brickell Biotech, Inc. was 100.00%, occurring on May 9, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -100% | Feb 18, 2000 | 5842 | May 9, 2023 | — | — | — |
| -65.29% | Jun 12, 1996 | 564 | Sep 3, 1998 | 312 | Nov 30, 1999 | 876 |
| -59.37% | Feb 3, 1994 | 295 | Apr 5, 1995 | 204 | Jan 25, 1996 | 499 |
| -29.05% | Jan 29, 1996 | 52 | Apr 11, 1996 | 21 | May 10, 1996 | 73 |
| -29.05% | Jul 6, 1993 | 43 | Sep 3, 1993 | 26 | Oct 12, 1993 | 69 |
Volatility Chart
The current Brickell Biotech, Inc. volatility is 14.90%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.